Response to 'Correspondence on 'Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study'' by Zheng <i>et al</i>.

Pappas, Dimitrios A; St John, Gregory; Etzel, Carol J; Fiore, Stefano; Blachley, Taylor; Kimura, Toshio; Punekar, Rajeshwari; Emeanuru, Kelechi; Choi, Jeannie; Boklage, Susan; Kremer, Joel M

Response to 'Correspondence on 'Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study'' by Zheng et al.

Pappas, Dimitrios A; St John, Gregory; Etzel, Carol J; Fiore, Stefano; Blachley, Taylor; Kimura, Toshio; Punekar, Rajeshwari; Emeanuru, Kelechi; Choi, Jeannie; Boklage, Susan; Kremer, Joel M.

Afiliação

Pappas DA; Division of Rheumatology, Department of Medicine, Columbia University Medical Center, New York, New York, USA dpappas@corrona.org.
St John G; Corrona, Albany Medical College and The Center for Rheumatology, Waltham, Massachusetts, USA.
Etzel CJ; Medical Affairs, Regeneron Pharmaceuticals, Tarrytown, New York, USA.
Fiore S; Corrona, Albany Medical College and The Center for Rheumatology, Waltham, Massachusetts, USA.
Blachley T; Medical Affairs, Sanofi, Bridgewater, New Jersey, USA.
Kimura T; Corrona, Albany Medical College and The Center for Rheumatology, Waltham, Massachusetts, USA.
Punekar R; Medical Analytics, Regeneron Pharmaceuticals, Tarrytown, New York, USA.
Emeanuru K; Real World Evidence Generation, Sanofi Genzyme, Cambridge, Massachusetts, USA.
Choi J; Corrona, Albany Medical College and The Center for Rheumatology, Waltham, Massachusetts, USA.
Boklage S; Health Economics and Value Assessment, Sanofi, Bridgewater, New Jersey, USA.
Kremer JM; Medical Affairs, Regeneron Pharmaceuticals, Tarrytown, New York, USA.

Ann Rheum Dis ; 81(11): e225, 2022 11.

Article em En | MEDLINE | ID: mdl-33177102

Assuntos

Antirreumáticos; Artrite Reumatoide; Produtos Biológicos; Antirreumáticos/uso terapêutico; Artrite Reumatoide/tratamento farmacológico; Produtos Biológicos/uso terapêutico; Humanos; Necrose; Sistema de Registros; Inibidores do Fator de Necrose Tumoral/uso terapêutico

Palavras-chave

arthritis; health care; outcome assessment; patient reported outcome measures; rheumatoid; tumor necrosis factor inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Produtos Biológicos / Antirreumáticos Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google